A. Tateishi et al., FEASIBILITY OF THE TITRATION METHOD OF MILD HYPOTHERMIA IN SEVERELY HEAD-INJURED PATIENTS WITH INTRACRANIAL HYPERTENSION, Neurosurgery, 42(5), 1998, pp. 1065-1069
OBJECTIVE: Clinical strategy to maximize effectiveness and to minimize
adverse influences remains to be determined for mild hypothermia ther
apy for traumatic brain injury. This study was conducted to evaluate t
he clinical feasibility of the titration method of mild hypothermia in
severely head-injured patients in whom a reduction in intracranial pr
essure was regarded as the target effect. METHODS: Nine consecutive pa
tients with severe head injury were studied. Patient age ranged betwee
n 18 and 66 years, Glasgow Coma Scale scores were equal to or less tha
n 8, and intracranial pressures were equal to or greater than 20 mm Hg
despite removal of intracranial hematoma and drugs, including glycero
l and thiopental. During a maximum of 6 days of hypothermia therapy, j
ugular venous blood or cerebrospinal fluid temperature was titrated to
reduce intracranial pressure to less than 20 mm Hg by means of repeat
ed intragastric cooling with our nasoduodenal tube and surface cooling
. The feasibility and the effects on systemic complications of this ti
tration method of mild hypothermia were evaluated. RESULTS: Intracrani
al pressure variably decreased from before to 3 hours after the beginn
ing of all procedures of cooling. The mean intracranial pressure signi
ficantly decreased from 24 to 15 mm Hg with cooling, while temperature
reduced an average of 2.0 degrees C. Four patients had systemic infec
tion complications. Increased C-reactive protein and decreased platele
t count were observed in all patients during hypothermia. The incidenc
e of good recovery and moderate disability according to the Glasgow Ou
tcome Scale was seven of nine patients. CONCLUSION: The titration meth
od of mild hypothermia to control intracranial hypertension in severel
y head-injured patients is clinically feasible. However, the method fa
iled to reduce the incidence of infectious and hematological complicat
ions.